|
| 38039965 | A road map for the treatment of pediatric diffuse midline glioma. | Cancer Cell | 2024 |
| 37509387 | Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma. | | 2023 |
| 35981900 | Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma. | | 2023 |
| 37577659 | Glioma-neuronal circuit remodeling induces regional immunosuppression. | bioRxiv | 2023 |
| 36944450 | Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch <i>et al</i>. | J Immunother Cancer | 2023 |
| 37378557 | Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma. | | 2023 |
| 37294768 | Translational imaging of TSPO reveals pronounced innate inflammation in human and murine CD8 T cell-mediated limbic encephalitis. | | 2023 |
| 35104791 | The immunology of low-grade gliomas. | Neurosurg Focus | 2022 |
| 35703183 | Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. | J Clin Invest | 2022 |
| 36002574 | RASA2 ablation in T cells boosts antigen sensitivity and long-term function. | Nature | 2022 |
| 35606815 | The future of cancer immunotherapy for brain tumors: a collaborative workshop. | Journal of Translational Medicine | 2022 |
| 35606087 | Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma. | Journal for ImmunoTherapy of Cancer | 2022 |
| 35855503 | Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma. | Current Opinion in Oncology | 2022 |
| 36497477 | Magnetic Resonance Spectroscopy Metabolites as Biomarkers of Disease Status in Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Treated with Glioma-Associated Antigen Peptide Vaccines. | Cancers (Basel) | 2022 |
| 34882581 | Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas. | J Clin Invest | 2022 |
| 35121998 | The current landscape of immunotherapy for pediatric brain tumors. | Nat Cancer | 2022 |
| 33225764 | Considerations when treating high-grade pediatric glioma patients with immunotherapy. | Expert Rev Neurother | 2021 |
| 33910979 | SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma. | Sci Transl Med | 2021 |
| 33575659 | Assessing Oximetry Response to Chimeric Antigen Receptor T-cell Therapy against Glioma with <sup>19</sup>F MRI in a Murine Model. | Radiol Imaging Cancer | 2021 |
| 33456708 | Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy. | Oncotarget | 2021 |
| 34193567 | IFN-γ- and IL-17-producing CD8 T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity. | Journal for ImmunoTherapy of Cancer | 2021 |
| 33499924 | The evolution of alternative splicing in glioblastoma under therapy. | Genome Biol | 2021 |
| 34083417 | Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma. | J Immunother Cancer | 2021 |
| 33496872 | Current Advances in Immunotherapy for Glioblastoma. | Curr Oncol Rep | 2021 |
| 33367885 | Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank. | Neuro Oncol | 2021 |
| 33232299 | Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade. | JCI Insight | 2021 |
| 32843491 | The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019. | J Immunother Cancer | 2020 |
| 32185647 | T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment. | Journal of Neuro-Oncology | 2020 |
| 31631402 | Cell penetrating peptide functionalized perfluorocarbon nanoemulsions for targeted cell labeling and enhanced fluorine-19 MRI detection. | Magnetic Resonance in Medicine | 2020 |
| 31728884 | Treatment-induced lesions in newly diagnosed glioblastoma patients undergoing chemoradiotherapy and heat-shock protein vaccine therapy. | J Neurooncol | 2020 |
| 31988324 | Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. | Nature Communications | 2020 |
| 32037183 | Tumor antigens in glioma. | Seminars in Immunology | 2020 |
| 32984905 | The current state of immunotherapy for primary and secondary brain tumors: similarities and differences. | Japanese Journal of Clinical Oncology | 2020 |
| 32817593 | Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. | J Clin Invest | 2020 |
| 33014387 | Introduction to immunotherapy for brain tumor patients: challenges and future perspectives. | Neuro-Oncology Practice | 2020 |
| 31154438 | Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. | Mol Cell Proteomics | 2019 |
| 31783779 | Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy). | Journal for ImmunoTherapy of Cancer | 2019 |
| 30568303 | Actively personalized vaccination trial for newly diagnosed glioblastoma. | Nature | 2019 |
| 30813960 | The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion. | J Immunother Cancer | 2019 |
| 30733620 | Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma. | Nature | 2019 |
| 30677574 | Immunotherapy for High-Grade Gliomas: A Clinical Update and Practical Considerations for Neurosurgeons. | World Neurosurg | 2019 |
| 31154440 | Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. | Mol Cell Proteomics | 2019 |
| 30740109 | Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy. | Frontiers in Immunology | 2018 |
| 30072578 | Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. | Mol Cell Proteomics | 2018 |
| 29871908 | Immunotherapy of Primary Brain Tumors: Facts and Hopes. | Clinical Cancer Research | 2018 |
| 30524896 | Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models. | OncoImmunology | 2018 |
| 29618666 | Peptide vaccine immunotherapy biomarkers and response patterns in pediatric gliomas. | JCI Insight | 2018 |
| 29203539 | Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. | J Exp Med | 2018 |
| 27889021 | Neuroimaging of Peptide-based Vaccine Therapy in Pediatric Brain Tumors: Initial Experience. | Neuroimaging Clin N Am | 2017 |
| 28724573 | A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. | Sci Transl Med | 2017 |